Tuberculosis Diagnostics - Global Market Outlook (2017-2023)
According to Stratistics MRC, the Global Tuberculosis Diagnostics market is accounted for $2.24 billion in 2016 and is expected to reach $3.30 billion by 2023 growing at a CAGR of 5.7% from 2016 to 2023. Increasing cases of tuberculosis is one of the major factor responsible for high market growth. Furthermore, rising government initiatives, growing requirement of POC in healthcare and increasing geriatric population are some factors that are positively affecting the market. However, lack of awareness among the patients is hindering the market.
Based on test type, diagnostic laboratory method segment dominated the global market as they are cost efficient and easy-to-perform. These tests also include smear microscopy and culture-based tests. The regions with high burden rely on these methodologies owing to their technical and financial inability to incorporate advanced technologies.
Depending on geography, Asia Pacific region is expected to provide profitable growth over the forecast period owing to its huge population base and high burden as well the rapid proliferation of this disease. Countries such as India, China, Afghanistan, and Indonesia have been recognized as the high burden countries. Hence government agencies and WHO have planned initiatives to fortify the force of diagnostic centers including laboratories and the screening networks.
Some of the key players in this market include Siemens, F.Hoffmann-La Roche AG, BioMérieux SA, Becton, Dickinson and Company, Alere, Inc., Hain Lifesciences GmBH, Abbott Laboratories, Cepheid, Akkoni, Hologic Corporation, AutoGenomics, iCubate, MARTI TB Diagnostics, Thermo Fisher Scientific, Inc., Sanofi and Qiagen.
End Users Covered:
Based on test type, diagnostic laboratory method segment dominated the global market as they are cost efficient and easy-to-perform. These tests also include smear microscopy and culture-based tests. The regions with high burden rely on these methodologies owing to their technical and financial inability to incorporate advanced technologies.
Depending on geography, Asia Pacific region is expected to provide profitable growth over the forecast period owing to its huge population base and high burden as well the rapid proliferation of this disease. Countries such as India, China, Afghanistan, and Indonesia have been recognized as the high burden countries. Hence government agencies and WHO have planned initiatives to fortify the force of diagnostic centers including laboratories and the screening networks.
Some of the key players in this market include Siemens, F.Hoffmann-La Roche AG, BioMérieux SA, Becton, Dickinson and Company, Alere, Inc., Hain Lifesciences GmBH, Abbott Laboratories, Cepheid, Akkoni, Hologic Corporation, AutoGenomics, iCubate, MARTI TB Diagnostics, Thermo Fisher Scientific, Inc., Sanofi and Qiagen.
End Users Covered:
- Diagnostic laboratories
- Hospitals
- Detection of drug resistance
- Radiographic method
- Diagnostic Laboratory methods
- Detection of latent infection
- Nucleic acid testing
- Phage assay
- Mantoux Test
- Cytokine detection assay
- Other Test Types
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY END USER
5.1 Introduction
5.2 Diagnostic laboratories
5.3 Hospitals
6 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TEST TYPE
6.1 Introduction
6.2 Detection of drug resistance
6.3 Radiographic method
6.4 Diagnostic Laboratory methods
6.4.1 Smear microscopy
6.4.2 Culture-based test
6.5 Detection of latent infection
6.6 Nucleic acid testing
6.7 Phage assay
6.8 Mantoux Test
6.9 Cytokine detection assay
6.10 Other Test Types
7 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 COMPANY PROFILING
9.1 Siemens
9.2 F.Hoffmann-La Roche AG
9.3 BioMérieux SA
9.4 Becton, Dickinson and Company
9.5 Alere, Inc.
9.6 Hain Lifesciences GmBH
9.7 Abbott Laboratories
9.8 Cepheid
9.9 Akkoni
9.10 Hologic Corporation
9.11 AutoGenomics
9.12 iCubate
9.13 MARTI TB Diagnostics
9.14 Thermo Fisher Scientific, Inc.
9.15 Sanofi
9.16 Qiagen
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY END USER
5.1 Introduction
5.2 Diagnostic laboratories
5.3 Hospitals
6 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY TEST TYPE
6.1 Introduction
6.2 Detection of drug resistance
6.3 Radiographic method
6.4 Diagnostic Laboratory methods
6.4.1 Smear microscopy
6.4.2 Culture-based test
6.5 Detection of latent infection
6.6 Nucleic acid testing
6.7 Phage assay
6.8 Mantoux Test
6.9 Cytokine detection assay
6.10 Other Test Types
7 GLOBAL TUBERCULOSIS DIAGNOSTICS MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 COMPANY PROFILING
9.1 Siemens
9.2 F.Hoffmann-La Roche AG
9.3 BioMérieux SA
9.4 Becton, Dickinson and Company
9.5 Alere, Inc.
9.6 Hain Lifesciences GmBH
9.7 Abbott Laboratories
9.8 Cepheid
9.9 Akkoni
9.10 Hologic Corporation
9.11 AutoGenomics
9.12 iCubate
9.13 MARTI TB Diagnostics
9.14 Thermo Fisher Scientific, Inc.
9.15 Sanofi
9.16 Qiagen
LIST OF TABLES
Table 1 Global Tuberculosis Diagnostics Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 3 Global Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 4 Global Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 5 Global Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 6 Global Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 7 Global Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 8 Global Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 9 Global Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 10 Global Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 11 Global Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 12 Global Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 13 Global Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 14 Global Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 15 Global Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 16 Global Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 17 North America Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 18 North America Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 19 North America Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 20 North America Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 21 North America Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 22 North America Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 23 North America Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 24 North America Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 25 North America Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 26 North America Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 27 North America Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 28 North America Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 29 North America Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 30 North America Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 31 North America Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 32 North America Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 33 Europe Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 34 Europe Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 35 Europe Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 36 Europe Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 37 Europe Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 38 Europe Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 39 Europe Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 40 Europe Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 41 Europe Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 42 Europe Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 43 Europe Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 44 Europe Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 45 Europe Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 46 Europe Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 47 Europe Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 48 Europe Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 49 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 50 Asia Pacific Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 51 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 52 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 53 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 54 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 55 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 56 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 57 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 58 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 59 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 60 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 61 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 62 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 63 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 64 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 65 South America Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 66 South America Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 67 South America Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 68 South America Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 69 South America Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 70 South America Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 71 South America Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 72 South America Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 73 South America Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 74 South America Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 75 South America Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 76 South America Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 77 South America Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 78 South America Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 79 South America Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 80 South America Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 81 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 82 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 83 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 84 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 85 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 86 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 87 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 88 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 89 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 90 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 91 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 92 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 93 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 94 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 95 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 96 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 1 Global Tuberculosis Diagnostics Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 3 Global Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 4 Global Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 5 Global Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 6 Global Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 7 Global Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 8 Global Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 9 Global Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 10 Global Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 11 Global Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 12 Global Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 13 Global Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 14 Global Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 15 Global Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 16 Global Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 17 North America Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 18 North America Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 19 North America Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 20 North America Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 21 North America Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 22 North America Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 23 North America Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 24 North America Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 25 North America Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 26 North America Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 27 North America Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 28 North America Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 29 North America Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 30 North America Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 31 North America Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 32 North America Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 33 Europe Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 34 Europe Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 35 Europe Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 36 Europe Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 37 Europe Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 38 Europe Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 39 Europe Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 40 Europe Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 41 Europe Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 42 Europe Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 43 Europe Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 44 Europe Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 45 Europe Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 46 Europe Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 47 Europe Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 48 Europe Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 49 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 50 Asia Pacific Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 51 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 52 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 53 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 54 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 55 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 56 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 57 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 58 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 59 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 60 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 61 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 62 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 63 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 64 Asia Pacific Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 65 South America Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 66 South America Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 67 South America Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 68 South America Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 69 South America Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 70 South America Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 71 South America Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 72 South America Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 73 South America Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 74 South America Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 75 South America Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 76 South America Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 77 South America Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 78 South America Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 79 South America Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 80 South America Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
Table 81 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Country (2014-2023) ($MN)
Table 82 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By End User (2014-2023) ($MN)
Table 83 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Diagnostic laboratories (2014-2023) ($MN)
Table 84 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Hospitals (2014-2023) ($MN)
Table 85 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Test Type (2014-2023) ($MN)
Table 86 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Detection of drug resistance (2014-2023) ($MN)
Table 87 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Radiographic method (2014-2023) ($MN)
Table 88 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Diagnostic Laboratory methods (2014-2023) ($MN)
Table 89 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Smear microscopy (2014-2023) ($MN)
Table 90 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Culture-based test (2014-2023) ($MN)
Table 91 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Detection of latent infection (2014-2023) ($MN)
Table 92 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Nucleic acid testing (2014-2023) ($MN)
Table 93 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Phage assay (2014-2023) ($MN)
Table 94 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Mantoux Test (2014-2023) ($MN)
Table 95 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Cytokine detection assay (2014-2023) ($MN)
Table 96 Middle East & Africa Tuberculosis Diagnostics Market Outlook, By Other Test Types (2014-2023) ($MN)
